This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Crista's passion for advocacy began when her youngest son, Colton, was diagnosed with intractable epilepsy just after he turned two. Crista Eggers is deeply committed to the advocacy and advancement of medical cannabis legalization in Nebraska.
The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. One in 26 people will develop epilepsy in their lifetime. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. appeared first on.
A newly published article in the Epilepsy & Behavior Journal highlights the findings of researchers at the University of Alabama at Birmingham after surveying healthcare providers on their attitudes and knowledge about cannabis, and has confirmed what most of us already knew– healthcare providers need more education on cannabis.
Patients who suffer from epilepsy , which affects some 3.4 This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. This is according to a recently published study featured in the peer-reviewed journal Epilepsy & Behavior. CBD, which constitutes a $2,770.8
The post Why CBD is Dangerous For Seizures and Epilepsy appeared first on Nature's Way Medicine ®. I recommend we all share this information with others so seizure patients across the globe will reconsider changing to a high-CBD strain that lacks the THC they depend on. .
Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy. Assembly Bill 20 , The Jake Honig Compassionate Use Medical Cannabis Act, institutes various changes to the program to better facilitate patients’ access to the substance.
This is the case with an 11-year-old epilepsy patient, whose plight was the catalyst for D.C.’s Zoey Carty has a sever case of frontal lobe epilepsy, leading to several seizures per day. For an epilepsy patient, consistent access to medication is critical, as a single missed dose could be dangerous (depending on the individual).
Unfortunately, this had a powerful impact on a small subset of residents—UK children suffering from epilepsy who had been dependent on imported medications to help control their illness. But for some children, especially those struggling to manage severe epilepsy, cannabis and cannabis-based medications have proven to be a powerful tool.
Between internet searches that bring up myths and falsehoods, medical professionals who aren’t properly educated about the plant, and marketing language designed to confuse , it’s easy for someone who is curious about cannabis to get the wrong information. Free cannabis education. And yes, it’s completely free!).
Primary conditions included neurological diseases such as MS and epilepsy, chronic pain from autoimmune diseases like fibromyalgia, back pain, cancer, insomnia, and psychiatric disorders such as anxiety, depression, and PTSD.
In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.
and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. His first initiative is co-authoring an original study on epilepsy using survey data gathered from RoC’s innovative Observational Research Registry (ORR). Under the Leadership of Nicolas Schlienz, Ph.D., COLORADO SPRINGS, Colo.–(BUSINESS
The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. Epilepsy Behav. (E-commerce sales of CBD in the U.S. Accessed October 17, 2022.
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. References Staff, T.
We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.
However, it is important to always keep in mind that a lot of what we currently know about cannabis and the keto diet is purely based on anecdotal evidence and educated speculation. In fact, a lot of people don’t realize that the keto diet was originally designed to treat seizures in children suffering from treatment resistant epilepsy.
This statistic accounts for medicines treating patients with epilepsy, anxiety, depression, chronic pain, and other illnesses. Although there is growing access to cannabis medicines, there is an increasing need for credible research and educational platforms. million people.
The Need for Cannabis Education Tailored to Patient and Doctor. But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. Education and Resources to Drive Medical Cannabis.
Medical marijuana is also known to be beneficial to those who deal with epilepsy and other seizure disorders. It seems to be especially useful to those with severe forms of epilepsy, such as Dravet Syndrome, which is a rare form of epilepsy that affects young children.
CBD proved to be life-changing for epilepsy patients, with some preliminary studies indicating that it could help with several other issues, like inflammation. But one particular area of concern is an observation during a landmark study in children with severe epilepsy. In some ways, the public was not entirely wrong.
Neurological Disorders: There is growing evidence that cannabis can have beneficial effects on neurological disorders like epilepsy and multiple sclerosis. However, education is key. Mental Health: Preliminary research suggests that CBD may have therapeutic potential for treating conditions such as anxiety and depression.
To make up for my lack of formal education in cannabinoids, I recently took an MMJ411 online course and I am now certified as a pharmacist in cannabinoids. These courses were excellent and provided clear goals and outcomes and I earned 10 Continuing Education points, although Israeli pharmacists do not need CMEs.
As legalization continues to be passed worldwide we hope (and will continue to educate) to see cannabis federally legal in the US and in most countries by 2022. After studying its effects, he introduced cannabis to physicians in England as a treatment for a wide range of conditions, including muscle spasms, rheumatism, epilepsy and pain.
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high. Shutterstock).
As a long-time cannabis activist, entrepreneur and educator in a career spanning 40 years, today DeAngelo is the CEO of Harborside Health Center in Oakland, California, and a regular speaker at international industry events. Here’s a list of the ten top U.S. cannabis movers and shakers in 2018. Steve DeAngelo. Emma Chasen. Joshua Kaplan.
Through working in collaboration with the global leaders in medical cannabis education and training, The Academy of Medical Cannabis , the clinic chain has amassed a team of skilled clinicians who have been trained to prescribe cannabis-based medicine. Increasing demand for medical cannabis.
The information below is meant as a guide: Qualifying Conditions: If a patient has any of the following conditions or has been determined to be terminal, he or she may qualify for low-THC or medical cannabis. PTSD (Post Traumatic Stress Disorder). ALS (Amyotrophic Lateral Sclerosis). Parkinson’s. MS (Multiple Sclerosis).
says it is expanding its medical cannabis product offerings for patients and related education for health professionals in Australia. Additionally, the company has also launched a new medical cannabis educational platform for Australian and New Zealand healthcare professionals. “On Via Hemp Gazette.
LifeCannMD was founded by Dr. Fernando Fandiño-Sende in Miami, and is dedicated to the evaluation, education, and treatment of patients who qualify for Medical Cannabis, since June 2017, Florida residents with certain qualifying conditions can obtain a Medical Marijuana recommendation for treatment.
To make up for my lack of formal education in cannabinoids, I recently took an MMJ411 online course and I am now certified as a pharmacist in cannabinoids. These courses were excellent and provided clear goals and outcomes and I earned 10 Continuing Education points, although Israeli pharmacists do not need CMEs.
The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result.
Even doses higher than 1,000mg have been safely administered in testing, and CBD is considered safe for children for the treatment of epilepsy. In fact, the US Food and Drug Administration recently approved the first marijuana-derived drug , Epidiolex, for the treatment of atypical epilepsy in children known as Dravet Syndrome.
However, dysregulation of the endocannabinoid system has been implicated in the pathogenesis of neurological disorders such as epilepsy, multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. Here are the basics of what you need to know.
The move marked the first time the DEA removed any form of cannabis from Schedule I and was due to the FDA’s approval of Epidiolex, a non-synthetic cannabis-derived medicine used to treat severe epilepsy. Educating employees about CBD and zero tolerance policies.
is the Medical Director of Canna-Centers Wellness and Education, a Los Angeles-based medical practice established in 2008, which is devoted to helping patients use cannabis for serious and chronic medical conditions. She has a special interest in treating children with intractable epilepsy, autism, and cancer. About Bonni S.
Despite research supporting its efficacy for the treatment of chronic pain, mood disorders, and seizures attributed to epilepsy, cannabis still draws proverbial eye rolls from a large proponent of healthcare practitioners. Point of care education continues to show great value in modern healthcare. Simplifying Medical Cannabis.
The Scotsman reports… The GP for a seven-year-old boy whose mother uses cannabis-based drugs to treat his epilepsy has agreed to write to the Scottish Government in an attempt to secure him a prescription. There’s nothing illegal about what’s happening but she’s having to shell out over £1,000 a month and it doesn’t seem fair.
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Epilepsy & behavior case reports 9 (2018): 10. The most important drug interactions can be predicted by comparing the CYP450 metabolic pathways used by CBD and other drugs.
Our caring team will also take the time to educate you about medical cannabis and how to maximize its benefits. These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. We remain committed to your health throughout the year as we provide follow up care.
Patient Education: Pennsylvania MMJ dispensaries often provide education and support to patients, helping them understand their treatment options and guiding them on responsible MMJ use. These conditions include cancer, epilepsy, multiple sclerosis, post-traumatic stress disorder (PTSD), and many others.
There is no doubt that CBD provides benefits, especially against epilepsy. WeedAdvisor’s Mission to Educate. . Now, this cannabinoid found in both hemp and marijuana (to different degrees) is a household name. But with popularity comes embellishment. Now, CBD has another potential medical role, this time as an antibiotic.
To address these concerns and provide clear, evidence-based answers to the most frequently asked questions about medical marijuana, we have compiled a comprehensive FAQ to help both patients and the general public make educated decisions about their healthcare options.
For Jackie, cannabis was the one medicine that had been missing from her daughter’s treatment for Aicardi Syndrome, a non-curable, rare brain malformation that is characterized by refractory epilepsy. … The lack of education in medical practices is the number one issue. After watching a CNN report on CBD, I did some exploring.
Lack of education means that marijuana is still deemed a “gateway drug” in Japan, where the government believes that it encourages other forms of narcotic abuse. Moving forward, the government plans on implementing new laws as a way of preventing drug abuse among young people.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content